These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 20567250)

  • 1. Activating and inhibitory receptors of natural killer cells.
    Pegram HJ; Andrews DM; Smyth MJ; Darcy PK; Kershaw MH
    Immunol Cell Biol; 2011 Feb; 89(2):216-24. PubMed ID: 20567250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
    J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
    Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
    Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Putting the natural killer cell in its place.
    O'Connor GM; Hart OM; Gardiner CM
    Immunology; 2006 Jan; 117(1):1-10. PubMed ID: 16423035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
    Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
    Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of natural killer cells: underlying molecular mechanisms revealed.
    Backström E; Kristensson K; Ljunggren HG
    Scand J Immunol; 2004; 60(1-2):14-22. PubMed ID: 15238069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells.
    Kusumi M; Yamashita T; Fujii T; Nagamatsu T; Kozuma S; Taketani Y
    J Reprod Immunol; 2006 Jun; 70(1-2):33-42. PubMed ID: 16488482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer.
    Llano M; Lee N; Navarro F; García P; Albar JP; Geraghty DE; López-Botet M
    Eur J Immunol; 1998 Sep; 28(9):2854-63. PubMed ID: 9754572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of self-ligands for activating natural killer cell receptors.
    Lam RA; Chwee JY; Le Bert N; Sauer M; Pogge von Strandmann E; Gasser S
    Ann Med; 2013 Jun; 45(4):384-94. PubMed ID: 23701136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
    Banerjee P; Feuer G; Barker E
    J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human natural killer cells: Molecular mechanisms controlling NK cell activation and tumor cell lysis.
    Moretta L; Bottino C; Pende D; Vitale M; Mingari MC; Moretta A
    Immunol Lett; 2005 Aug; 100(1):7-13. PubMed ID: 16109445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation and self-tolerance of natural killer cells.
    Gasser S; Raulet DH
    Immunol Rev; 2006 Dec; 214():130-42. PubMed ID: 17100881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal transduction during activation and inhibition of natural killer cells.
    Watzl C; Long EO
    Curr Protoc Immunol; 2010 Aug; Chapter 11():Unit 11.9B. PubMed ID: 20814939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural immunology and crystallography help immunologists see the immune system in action: how T and NK cells touch their ligands.
    Chen Y; Shi Y; Cheng H; An YQ; Gao GF
    IUBMB Life; 2009 Jun; 61(6):579-90. PubMed ID: 19472182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reciprocal age related change in natural killer cell receptors for MHC class I.
    Lutz CT; Moore MB; Bradley S; Shelton BJ; Lutgendorf SK
    Mech Ageing Dev; 2005; 126(6-7):722-31. PubMed ID: 15888327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing multivalent proteins based on natural killer cell receptors and their ligands as immunotherapy for cancer.
    Smits NC; Coupet TA; Godbersen C; Sentman CL
    Expert Opin Biol Ther; 2016 Sep; 16(9):1105-12. PubMed ID: 27248342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cell signaling pathways.
    Vivier E; Nunès JA; Vély F
    Science; 2004 Nov; 306(5701):1517-9. PubMed ID: 15567854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene.
    Cantoni C; Biassoni R; Pende D; Sivori S; Accame L; Pareti L; Semenzato G; Moretta L; Moretta A; Bottino C
    Eur J Immunol; 1998 Jan; 28(1):327-38. PubMed ID: 9485212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The balancing act: inhibitory Ly49 regulate NKG2D-mediated NK cell functions.
    Malarkannan S
    Semin Immunol; 2006 Jun; 18(3):186-92. PubMed ID: 16737823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.
    Pérez-Villar JJ; Melero I; Navarro F; Carretero M; Bellón T; Llano M; Colonna M; Geraghty DE; López-Botet M
    J Immunol; 1997 Jun; 158(12):5736-43. PubMed ID: 9190923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.